Literature DB >> 36155829

An ultrasensitive and disposable electrochemical aptasensor for prostate-specific antigen (PSA) detection in real serum samples.

Canan Özyurt1, İnci Uludağ2, Mustafa Kemal Sezgintürk3.   

Abstract

In this study, we constructed a disposable indium tin oxide polyethylene terephthalate film (ITO-PET)-based electrochemical aptasensor for analyzing prostate-specific antigen (PSA), one of the most important biomarkers of prostate cancer. Because of their clinical importance, building PSA biosensing systems with high sensitivity and stability is essential. However, it still presents significant difficulties, such as low detection limits. We designed a platform to covalently bind the amino-terminated aptamer by modifying the ITO-PET surface with carboxyethylsilanetriol (CTES) to obtain a self-assembled monolayer (SAM). We also evaluated the potential for use in real human serum samples by investigating the optimal operating conditions and analytical performance characteristics of the developed biosensor. The design we present here exhibits excellent precision, with a limit of detection (LOD) as low as 8.74 fg/mL PSA. The broad linear detection range of the biosensor under optimal conditions was determined as 1.0-1500 fg/mL. The dissociation constant (Kd) for the aptamer was also calculated as 46.28 ± 5.63 nM by evaluating the impedimetric response as a function of PSA concentration. The aptasensor displayed considerable repeatability (1.3% RSD) and reproducibility (7.51% RSD) and good storage stability (98.34% of the initial activity for 8 weeks). Additionally, we demonstrated that the technique we developed was quite efficient in estimating the kinetics of aptamer-analyte interactions by determining the Kd and single-frequency impedance (SFI) data. In conclusion, we proposed a selective and sensitive biosensor with the potential for clinical application and superior performance in real serum samples.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aptamer; Aptasensor; Biosensor; Electrochemical impedance spectroscopy; Prostate cancer; Prostate-specific antigen

Year:  2022        PMID: 36155829     DOI: 10.1007/s00216-022-04309-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  24 in total

1.  Single chip SPR and fluorescent ELISA assay of prostate specific antigen.

Authors:  J Breault-Turcot; H-P Poirier-Richard; M Couture; D Pelechacz; J-F Masson
Journal:  Lab Chip       Date:  2015-12-07       Impact factor: 6.799

2.  A label-free fluorescent aptasensor based on HCR and G-quadruplex DNAzymes for the detection of prostate-specific antigen.

Authors:  Ruirui Zhao; Lu Zhao; Haidi Feng; Xiaoliang Chen; Huilin Zhang; Yunfeng Bai; Feng Feng; Shaomin Shuang
Journal:  Analyst       Date:  2021-02-22       Impact factor: 4.616

3.  Electrochemical impedance spectroscopy for study of aptamer-thrombin interfacial interactions.

Authors:  Xiaoxia Li; Lihua Shen; Dongdong Zhang; Honglan Qi; Qiang Gao; Fen Ma; Chengxiao Zhang
Journal:  Biosens Bioelectron       Date:  2008-02-08       Impact factor: 10.618

4.  [Clinical evaluation of chemiluminescence immunoassay PSA (ACS-PSA) for detection of prostate cancer].

Authors:  T Adachi; K Moriya; K Esaki
Journal:  Hinyokika Kiyo       Date:  1998-07

5.  A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer.

Authors:  Shokoufeh Hassani; Armin Salek Maghsoudi; Milad Rezaei Akmal; Soheila Rahmani Rahmani; Pouria Sarihi; Mohammad Reza Ganjali; Parviz Norouzi; Mohammad Abdollahi
Journal:  J Pharm Pharm Sci       Date:  2020       Impact factor: 2.327

6.  Electrochemical aptamer-based biosensor developed to monitor PSA and VEGF released by prostate cancer cells.

Authors:  Bruno P Crulhas; Agnieszka E Karpik; Flávia K Delella; Gustavo R Castro; Valber A Pedrosa
Journal:  Anal Bioanal Chem       Date:  2017-10-14       Impact factor: 4.142

7.  Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.

Authors:  Thomas A Stamey; Iain M Johnstone; John E McNeal; Arthur Y Lu; Cheryl M Yemoto
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

8.  The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report.

Authors:  Eric A Klein; Arnon Chait; Jason M Hafron; Kenneth M Kernen; Kannan Manickam; Andrew J Stephenson; Mathew Wagner; Hui Zhu; Aimee Kestranek; Boris Zaslavsky; Mark Stovsky
Journal:  Eur Urol       Date:  2017-04-07       Impact factor: 20.096

9.  Cell-based immobilization strategy for sensitive piezoelectric immunoassay of total prostate specific antigen.

Authors:  Yanjun Ding; Haixia Lu; Guorong Shi; Jia Liu; Guoli Shen; Ruqin Yu
Journal:  Biosens Bioelectron       Date:  2008-03-29       Impact factor: 10.618

10.  Development and Evaluation of an Immunoglobulin Y-Based ELISA for Measuring Prostate Specific Antigen in Human Serum.

Authors:  Agnieszka Łupicka-Słowik; Renata Grzywa; Ewa Leporowska; Danuta Procyk; Józef Oleksyszyn; Marcin Sieńczyk
Journal:  Ann Lab Med       Date:  2019-07       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.